DE2800108A1 - Mittel zur behandlung von augenkrankheiten - Google Patents
Mittel zur behandlung von augenkrankheitenInfo
- Publication number
- DE2800108A1 DE2800108A1 DE19782800108 DE2800108A DE2800108A1 DE 2800108 A1 DE2800108 A1 DE 2800108A1 DE 19782800108 DE19782800108 DE 19782800108 DE 2800108 A DE2800108 A DE 2800108A DE 2800108 A1 DE2800108 A1 DE 2800108A1
- Authority
- DE
- Germany
- Prior art keywords
- hormone
- means according
- eye
- treatment
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/066—TRH, thyroliberin, thyrotropin releasing hormone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP52000499A JPS6047244B2 (ja) | 1977-01-05 | 1977-01-05 | 薬剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2800108A1 true DE2800108A1 (de) | 1978-07-13 |
Family
ID=11475440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19782800108 Withdrawn DE2800108A1 (de) | 1977-01-05 | 1978-01-03 | Mittel zur behandlung von augenkrankheiten |
Country Status (6)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4665089A (en) * | 1985-03-21 | 1987-05-12 | Massachusetts Institute Of Technology | Process for preventing or reversing cataract formation using protein modification reagents |
| CN1011118B (zh) * | 1986-06-13 | 1991-01-09 | 天津医学院附属医院 | 治疗白内障的眼药水的制药方法 |
| US11857608B2 (en) | 2017-03-09 | 2024-01-02 | Diamedica Inc. | Dosage forms of tissue kallikrein 1 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3746697A (en) * | 1969-09-19 | 1973-07-17 | K Folkers | Tripeptide having the activity of the thyrotropin releasing hormone |
| DE2410821A1 (de) * | 1974-03-07 | 1975-09-18 | Hoechst Ag | Pharmazeutische kombinationspraeparate mit psychotroper wirkung und verfahren zu ihrer herstellung |
| US3932623A (en) * | 1974-06-18 | 1976-01-13 | Wilson Ian C | Method of treating schizophrenia |
| JPS51118841A (en) * | 1975-04-03 | 1976-10-19 | Takeda Chem Ind Ltd | A drug for improving and treating clouding of consciousness |
| AU504840B2 (en) * | 1975-09-09 | 1979-11-01 | Takeda Chemical Industries Ltd | Medicinal compositions |
-
1977
- 1977-01-05 JP JP52000499A patent/JPS6047244B2/ja not_active Expired
- 1977-12-29 US US05/865,722 patent/US4150120A/en not_active Expired - Lifetime
- 1977-12-30 GB GB54285/77A patent/GB1596180A/en not_active Expired
-
1978
- 1978-01-03 DE DE19782800108 patent/DE2800108A1/de not_active Withdrawn
- 1978-01-03 NL NL7800065A patent/NL7800065A/xx not_active Application Discontinuation
- 1978-01-04 FR FR7800169A patent/FR2376664A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5386009A (en) | 1978-07-29 |
| US4150120A (en) | 1979-04-17 |
| FR2376664B1 (US20030199744A1-20031023-C00003.png) | 1982-10-15 |
| JPS6047244B2 (ja) | 1985-10-21 |
| FR2376664A1 (fr) | 1978-08-04 |
| GB1596180A (en) | 1981-08-19 |
| NL7800065A (nl) | 1978-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60118859T2 (de) | Pharmazeutische Zusammensetzung enthaltend Trehalose zur ophthalmischen Verwendung | |
| DE3788004T2 (de) | Verwendung von Tetrahydrocortisol in der Therapie von Glaukom. | |
| DE3005208A1 (de) | Verwendung von acylcarnitin in arzneimitteln zur behandlung von stoerungen im gehirn-metabolismus | |
| DE2523998A1 (de) | Pharmazeutische zubereitung fuer die behandlung der schizophrenie | |
| DE3137125C2 (US20030199744A1-20031023-C00003.png) | ||
| EP0752246A2 (de) | Kappa-Opiate für entzündliche Darmerkrankungen | |
| DE69013431T2 (de) | Anthocyanidine zur Behandlung von Augenkrankheiten. | |
| DE69829290T2 (de) | Verwendung von alkanoylcarnitinderivaten zur behandlung von hyperaktivität mit aufmerksamkeitsstörungen | |
| DE3643119A1 (de) | Therapeutische zusammensetzung fuer diabetes-komplikationen | |
| DE3344173C2 (de) | Verwendung von alkanoyl-l-carnitin zur behandlung von myopathien oder muskulaeren dystrophien | |
| DE2800108A1 (de) | Mittel zur behandlung von augenkrankheiten | |
| DE69937574T2 (de) | Verwendung des pharmazeutischen präparates "histochrome" zur behandlung des akuten herzinfarkts und ischämischer herzerkrankungen | |
| DE3141970C2 (US20030199744A1-20031023-C00003.png) | ||
| DE2611976A1 (de) | Pharmazeutisches praeparat zur besserung und wiederherstellung bei verminderten bewusstseinszustaenden | |
| DE1900772C3 (de) | Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel | |
| DE2131679A1 (de) | 3,4,5-Trimethoxybenzamidocarbonsaeure und ihre Salze sowie Arzneipraeparate | |
| DE2633891C2 (de) | Tris-(hydroxymethyl)-aminomethansalz der 2-(5-Benzoylthienyl)-α-methylessigsäure, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen | |
| DE2349186C2 (de) | Arzneimittel zur Verbesserung der Zellatmung, der Herzmuskelleistung und der Hirnfunktion | |
| DE3688503T2 (de) | Erhöhung des ausfliessens wässriger körperfluessigkeit. | |
| DE2429034A1 (de) | Naehrfluessigkeit zur parenteralen verabfolgung | |
| EP0484581B1 (de) | Verwendung von Thromboxan-A2-Antagonisten zur Verhinderung von degenerativen Vorgängen im penilen Gewebe | |
| EP0001124A1 (de) | Neue Arzneimittelmischungen zur Verbesserung der Glucoseverwertung in den Zellen und Senkung des Blutzuckerspiegels | |
| DE2525064A1 (de) | Arzneimittel und verfahren zu seiner herstellung | |
| EP0144489B1 (de) | Verwendung eines zerebral und peripher wirkenden Antihypoxidotikums | |
| DE60304458T2 (de) | Verwendung eines l-ascorbinsäuresalzes zur herstellung einer pharmazeutischen zusammensetzung für die ophthalmische topische anwendung zur verbesserung des l-ascorbinsäurespiegels im auge |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8141 | Disposal/no request for examination |